Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
10/9/2008
 
First Published:
1/18/2008
1.
Phase II Diagnostic Study of F-18 16 alpha-Fluoroestradiol Imaging in Predicting Response in Women Receiving First-Line Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Diagnostic
Active
18 and over
NCI
UWCC-6590
6590, 8052, NCT00602043
Last Modified:
10/22/2007
 
First Published:
8/6/2006
2.
Early Assessment of Response By Fludeoxyglucose-Positron Emission Tomography in Patients With Hormone Receptor-Positive or HER-2/neu-Positive Breast Cancer Treated With Aromatase Inhibitors or Trastuzumab (Herceptin®)
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Active
18 and over
NCI
UWCC-UW-6213
UWCC-06-0445-H/D, NCT00362973
3.
Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Active
18 and over
Other
BR-1-0093
NCT00358098
4.
Positron Emission Tomography (PET) Using Hormone Receptor Ligands in Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Active
18 and over
Other
05-088
NCT00647790
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute